How can (bio)pharmaceutical companies contribute to improving global access to essential medications?
In today's rapidly evolving biopharmaceutical landscape, the collaboration between innovative biopharmaceutical companies and resource-rich CDMOs is vital for ensuring global access to essential medications. In this roundtable discussion, Justin Kong, Associate Director of Project Management, explores how these strategic partnerships are accelerating the delivery of life-saving treatments to patients worldwide.
In today's rapidly evolving biopharmaceutical landscape, the collaboration between innovative biopharmaceutical companies and resource-rich CDMOs is vital for ensuring global access to essential medications. In this roundtable discussion, Justin Kong, Associate Director of Project Management, explores how these strategic partnerships are accelerating the delivery of life-saving treatments to patients worldwide.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article